STOCK TITAN

X4 Pharmaceuticals: Venrock reports 7.6% passive stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

X4 Pharmaceuticals, Inc. (XFOR) is the issuer in an amended Schedule 13G reporting that a group beneficially owned 7,644,072 shares, or 7.6%, as of September 30, 2026. The reporting group includes Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, and voting members Nimish Shah and Bong Y. Koh.

The shares were held by the three investment vehicles: 3,502,608 by Venrock Healthcare Capital Partners III, L.P.; 350,567 by VHCP Co-Investment Holdings III, LLC; and 3,790,897 by Venrock Healthcare Capital Partners EG, L.P. Each reporting person reported shared voting and dispositive power over 7,644,072 shares and zero sole voting or dispositive power. The 7.6% calculation used 100,903,502 shares outstanding as of September 30, 2026.

Beneficial ownership reported by each reporting person 7,644,072 shares As of September 30, 2026
Class ownership percentage 7.6% As of September 30, 2026
Issuer shares outstanding 100,903,502 shares As of September 30, 2026; basis for the reported ownership percentage
Shares held by Venrock Healthcare Capital Partners III, L.P. 3,502,608 shares As of September 30, 2026
Shares held by VHCP Co-Investment Holdings III, LLC 350,567 shares As of September 30, 2026
Shares held by Venrock Healthcare Capital Partners EG, L.P. 3,790,897 shares As of September 30, 2026
beneficially owned regulatory
"aggregate number of shares of common stock ... beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power regulatory
"Shared Voting Power 7,644,072.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 7,644,072.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many XFOR shares did the Venrock reporting group beneficially own?

The group reported beneficial ownership of 7,644,072 XFOR shares, or 7.6%, as of September 30, 2026. Each of the reporting persons listed that same aggregate amount and percentage.

Which entities held the XFOR shares reported by the Venrock group?

The reported shares were held by Venrock Healthcare Capital Partners III, L.P. (3,502,608 shares), VHCP Co-Investment Holdings III, LLC (350,567 shares), and Venrock Healthcare Capital Partners EG, L.P. (3,790,897 shares). VHCP Management III, LLC and VHCP Management EG, LLC serve as managers or general partners, and Nimish Shah and Bong Y. Koh are their voting members.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





98420X202

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Venrock Healthcare Capital Partners III, L.P.
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
VHCP Co-Investment Holdings III, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management III, LLC, its Manager, By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
Venrock Healthcare Capital Partners EG, L.P.
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management EG, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
VHCP Management III, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
VHCP Management EG, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
Nimish Shah
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Attorney-in-fact
Date:11/16/2026
Bong Y. Koh
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Attorney-in-fact
Date:11/16/2026
Exhibit Information

Exhibit 24.1 Power of Attorney for Bong Y. Koh (incorporated by reference to Exhibit 24.1 to the Reporting Persons' Schedule 13G filed with the SEC on September 21, 2026). Exhibit 24.2 Power of Attorney for Nimish P. Shah (incorporated by reference to Exhibit 24.2 to the Reporting Persons' Schedule 13G filed with the SEC on September 21, 2026). Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G filed with the SEC on September 21, 2026).

Keep reading